Resurgence is a major concern after malaria elimination. After the initiation of the elimination program on Aneityum Island in 1991, microscopy showed that Plasmodium falciparum disappeared immediately, whereas P. vivax disappeared from 1996 onward, until P. vivax cases were reported in January 2002. By conducting malariometric surveys of the entire population of Aneityum, we investigated the age distribution of individuals with parasites during this epidemic in the context of antimalarial antibody levels and parasite antigen diversity. In July 2002, P. vivax infections were detected by microscopy in 22/759 individuals: 20/298 born after the beginning of the elimination program in 1991, 2/126 born between 1982 and 1991, and none of 335 born before 1982. PCR increased the number of infections detected to 77, distributed among all age groups. Prevalences were 12.1%, 16.7%, and 6.0%, respectively (P < 0.001). In November, a similar age pattern was found, but with fewer infections: 6/746 and 39/741 individuals were found to be infected by microscopy and PCR, respectively. The frequencies of antibody responses to P. vivax were significantly higher in individuals born before 1991 than in younger age groups and were similar to those on Malakula Island, an area of endemicity. Remarkably low antigen diversity (h, 0.15) of P. vivax infections was observed on Aneityum compared with the other islands (h, 0.89 to 1.0). A P. vivax resurgence was observed among children and teenagers on Aneityum, an age distribution similar to those before elimination and on islands where P. vivax is endemic, suggesting that in the absence of significant exposure, immunity may persist, limiting infection levels in adults. The limited parasite gene pool on islands may contribute to this protection.
R
ecently, the scaling up of malaria control efforts in countries where the disease is endemic has shown some promising results (1, 2) . This has led to renewed interest in malaria elimination, with 39 countries stating their commitment to achieve elimination (3) . Since these countries are all positioned along the margins of areas of endemicity, the prevention of reinfection and resurgence is an integral component of any elimination campaign. In the Asia Pacific region, the unique challenge for elimination relates to the relatively high proportion of Plasmodium vivax infections (4) . Islands provide natural ecological experiments with great potential for intervention studies and have demonstrated some early successes in malaria elimination (5) . Vanuatu consists of 68 islands in the Southwest Pacific with a high linguistic diversity. Despite different waves of human colonization, unstable malaria transmission has continued probably since the first human settlement 4,000 years ago (6) . Aneityum, the southernmost island in Vanuatu, is located at the southeast edge of the range of malaria transmission in the Pacific. To examine the feasibility of malaria elimination, an integrated control program, combining mass drug administration (MDA) with vector control, was initiated on Aneityum in 1991. Eight years later, it was concluded that malaria can be eliminated from isolated islands if there is a high degree of community commitment (7) . One major concern is the possible reintroduction of infection due to interisland human movement. To our knowledge, Aneityum is the only island in recent times where malaria elimination has been successfully maintained for more than a decade. Thus, observations from Aneityum can offer important insights into concerns regarding the loss of antimalarial immunity following elimination and how this might impact disease burdens in potential resurgences. An epidemic of P. vivax on Aneityum in 2002 provided us with an opportunity to investigate the age patterns of individuals with newly detected infections in the context of population-level antibody responses to P. vivax and parasite antigen diversity. Individuals born before elimination had considerably fewer episodes of parasitemia than those born after elimination. Our findings indicate that protective immunity against P. vivax infections persists for a long time, at least 10 years, after the initiation of malaria elimination efforts and thus the absence of exposure to recurrent infections.
MATERIALS AND METHODS
Interventions and surveys. Weekly MDA of chloroquine, pyrimethamine-sulfadoxine, and primaquine to the entire population (718 inhabitants) of Aneityum Island was carried out for 9 weeks in 1991, before the onset of the rainy season. Simultaneously, insecticide-treated bed nets (ITNs) were distributed to the entire population. Larvivorous fish were also introduced into several identified Anopheles farauti breeding sites (7) . Since 1991, community-based surveillance and vector control measures, including larvivorous fish and the original universal distribution of ITNs (0.94 net per villager), with annual reimpregnation, have been maintained continuously, even after the disappearance of indigenous malaria cases (7) . After the MDA, annual microscopy surveys of the whole island population showed the complete absence of Plasmodium falciparum, while P. vivax disappeared from 1996 onward. Two imported cases were documented: 1 P. vivax case in February 1993 and 1 P. falciparum case in June 1999 (7) . In January 2002, a malaria epidemic was reported through passive case detection by community microscopists. In 2001, only 1 parasitepositive case among a total of 247 blood slides examined was recorded, compared with 67 positive cases in 240 slides during the first 3 months of 2002 (G. Taleo and A. Kaneko, unpublished data). Here we present the results of malariometric surveys for the entire population of Aneityum in August 2000 and in June and November 2002, conducted according to the protocol described in reference 6. Additionally, serological responses to P. falciparum and P. vivax parasites were assessed from surveys conducted in 1998 on Aneityum as well as on Malakula and Futuna Islands (overall sample size, 1,313). Molecular analysis of antigen diversity for P. vivax infections was also carried out by comparing the results of surveys conducted in 2002 on Aneityum with those of previous surveys on 6 other Vanuatu islands. During the surveys, finger prick blood samples collected on filter paper (31 ET Chr; Whatman, Maidstone, United Kingdom) were stored desiccated at Ϫ20°C for serological analysis, molecular analysis of the antigen diversity of P. vivax in infected samples, and detection of submicroscopic parasite infections by PCR.
Written informed consent was obtained from all subjects or, for children (individuals Ͻ15 years old), from their guardians. The standard doses of chloroquine and primaquine were administered to microscopypositive individuals. Individuals with detected positive cases were asked about their history of interisland movement within the past 1 year. This study was approved by the Vanuatu Department of Health and by the Ethical Research Committee of Karolinska Institutet.
Serological analysis. Humoral responses to malaria parasites were evaluated in samples collected on Aneityum in 1998, 7 years after the initial intervention in 1991, and, for comparison, in samples collected on Malakula, an area of mesoendemicity, in 1998 and on Futuna, where malaria is not endemic, in 1997 (7). For erythrocyte-stage antigens, all 688 residents of Aneityum were studied, while 332 Malakula and 293 Futuna subjects were selected by following a stratification by age and place from our survey records (i.e., samples were randomly selected in proportion to total samples for a given age and location). A similar stratification was employed to study the responses to circumsporozoite proteins (CSPs) in 100 residents of Aneityum and in 99 residents each of Malakula and Futuna.
Antigens. In vitro cultures of the P. falciparum parasite (laboratory strain F32) were synchronized, and sonicates of late-stage-infected erythrocytes were used as crude P. falciparum antigen, as described previously (8) . Crude P. vivax antigen was prepared from acutely ill P. vivax patients as described previously (9) . After estimation of the protein content, the crude extract was stored at Ϫ80°C until use. Recombinant P. vivax CSPs (VK210 and VK247 types) were expressed and affinity purified as described previously (10) .
Serological methods. Sera were extracted from blood samples spotted onto filter paper and were eluted into 500 l (final serum dilution, 1:100) of phosphate-buffered saline containing 0.05% Tween and 0.5% bovine serum albumin as described previously (11) . Samples were further diluted 1:10, resulting in a 1:1,000 dilution for the determination of antimalarial IgG antibodies by enzyme-linked immunosorbent assays (ELISAs) as described previously (12) .
A cutoff for antibody positivity was defined by pooling values from all sites, using a mixture model (13) . The mixture model uses the antibody binding data from all samples tested and fits 2 Gaussian distributions, a narrow distribution of "seronegative" results and a broader distribution of "seropositive" results, using maximum-likelihood methods. The mean ELISA values of the Gaussian distribution corresponding to the seronegative population plus 3 standard deviations (SD) were used to define the cutoff for seropositivity.
Data analysis. To compare levels of P. falciparum and P. vivax transmission between the islands studied, the seroconversion rate (SCR; the rate at which individuals become antibody positive per year, a metric analogous to the force of infection) was estimated by fitting a simple reversible catalytic model to the measured seroprevalence, with age as a continuous variable, using maximum-likelihood methods (13) . For these models, only individuals aged 1 year or older were included, in order to exclude the effect of maternally derived antibodies in infants. Additionally, for Aneityum, confirmation of temporal changes in malaria transmission was explored by fitting models in which the SCR is allowed to change at a single time point. The statistical significance of the change was identified using likelihood ratio tests against models with no change, and profile likelihoods were plotted in order to determine confidence intervals (CIs) for the estimated time of the change (14) .
Molecular analysis of parasite antigen diversity. Parasite genetic diversity was examined by sequencing of the P. vivax merozoite surface protein 1 gene (Pvmsp1) and circumsporozoite protein gene (Pvcsp) for the P. vivax cases detected by microscopy in 2 malariometric surveys of the entire population of Aneityum during the 2002 outbreak (n, 28) and comparing the results with those detected by microscopy during previous surveys on 6 other Vanuatu islands (1996 to 2002) (n, 178). The parasite rates detected during the surveys on these islands are shown in Fig. 3 .
Parasite genomic DNA was extracted from blood spots on filter paper by using a QIAamp DNA Blood Minikit (Qiagen, MD). A DNA fragment covering the 5= region of Pvmsp1 was amplified by PCR using forward and reverse primers PvF0 (5=-CCAGTGTTCGTACATCTTTAAACC-3=) and PvR5 (5=-GTTGTACTTGTCAATTTGG-3=) (15), respectively, followed by nested PCR amplification using primers PvF0-2 (5=-CGTACATCTTT AAACCCCACACACT-3=) and PvR5. The PCR conditions have been described previously (15) . The nested PCR product was purified using a QIAquick PCR purification kit (Qiagen), and an ϳ0.4-kb region (blocks 5 and 6) beginning at nucleotide position 1996 of P. vivax strain Sal-I (GenBank accession AF435593) was sequenced using the BigDye Terminator cycle sequencing kit (version 3.1) (Applied Biosystems, Foster City, CA) in an ABI 3100 sequencer (Applied Biosystems). Full-length Pvcsp was amplified by PCR using forward and reverse primers PvCSP-F1 (5=-TGTTACATCCGTTCGAACAAGTTCTGTTCT-3=) and PvCSP-R1 (5=-TCATATCGTGTTTTCTAGAATTGCACAACT-3=), respectively, and was sequenced as described above.
Of the 206 P. vivax cases, 165 (27 from Aneityum and 138 from other islands) and 125 (25 and 100) cases were successfully sequenced for Pvmsp1 and Pvcsp, respectively. Mixed infections, as detected from overlapping peaks in electropherograms, were excluded from further analysis, but those isolates showing clearly separable major and minor peaks (where the minor peak height was less than 40% of the major peak height) were recovered (23 isolates for Pvcsp and 6 for Pvmsp1), in which only major peaks were adopted. Genotype diversity or expected heterozygosity (h) was calculated as described previously (16) .
Detection of submicroscopic parasite infections by PCR. DNA was extracted from filter paper blots by using a QIAamp DNA Minikit (Qiagen, CA, USA). A mitochondrial-DNA-based PCR was newly designed to detect the 4 human malaria species. By use of test samples from Vanuatu and Kenya, the sensitivity of the new PCR method for each of the 4 human species was slightly improved over that of an alternative method (17) (see text and Tables S1 to S4 in the supplemental material). The prevalences of infection (as determined by PCR or microscopy) for the different age groups were compared using the chi-square test.
Nucleotide sequence accession numbers. The sequences reported in this study have been deposited in the DDBJ/EMBL/GenBank database (accession no. AB539022 to AB539045 and AB539540 to AB539553).
RESULTS
Malariometric surveys on Aneityum Island. In a survey of the entire population on Aneityum in August 2000, a total of 903 individuals were examined. They consisted of 619 Aneityum islanders and 284 visitors from other islands, staying temporarily for a church meeting on Aneityum. Among the Aneityum islanders, no parasite-positive cases were detected by microscopy, but 2 P. vivax infections were detected by PCR (2/617 individuals [for 2 islanders, samples were not available]), for an 11-year-old girl and a 24-year-old male with no recent travel history. Among the visitors, we confirmed 1 case of P. falciparum infection by microscope and 28 positive cases (28/283 [for 1 visitor, no sample was available]) by PCR, which consisted of 20 P. vivax, 5 P. falciparum, 1 Plasmodium malariae, and 2 mixed (P. falciparum and P. vivax) infections. The mixed infections were not double-counted in the total number of positive cases (see Table S5 in the supplemental material).
During the survey conducted in July 2002 on Aneityum (Fig.  1a) , which covered a total of 759 islanders, 22 P. vivax infections were confirmed by microscopy: 20 infections among 298 children born after 1991 (aged 0 to 10 years) and 2 infections among 126 teenagers born between 1982 and 1991 (11 to 20 years). Parasite counts for these infections ranged from 80 to 3,840 parasites/l of blood (median, 400). No microscopy-positive infections were seen among the 339 adults born before 1982 (older than 20 years). A total of 77 P. vivax infections were detected by PCR and were more evenly distributed among all age groups than those detected by microscopy only (Fig. 1a) . All microscopy-positive cases were PCR positive. Thus, the total parasite positivity rates were 12.1%, 16.7%, and 5.97% for children, teenagers, and adults, respectively (P, Ͻ0.001 [ 2 , 11.46] for comparison of children and teenagers with adults). In a subsequent survey conducted in November 2002 (Fig. 1b) , 6 P. vivax infections were confirmed by microscopy only among 290 children born after 1991. Parasite counts ranged from 80 to 7,840 parasites/l of blood (median, 560). A total of 39 P. vivax infections were detected by PCR; these were distributed among all age groups (Fig. 1b) . Again, all microscopy-positive cases were PCR positive, and the P. vivax positivity rates were 8.71%, 6.92%, and 1.54% for children, teenagers, and adults, respectively, with relations similar to those for the July survey (P, Ͻ0.001 [ 2 , 15.95] for comparison of children and teenagers with adults). Seven individuals (3 children and 4 teenagers) were positive by PCR in both the July and November surveys.
For these P. vivax-positive individuals on Aneityum, no recent travel history was recorded. One P. falciparum infection of a 26-year-old male with a history of recent travel to Tanna Island was identified by PCR in the November survey. The P. vivax infections detected by microscopy and PCR in 2002 were distributed over the whole area of Aneityum Island. Among the total of 28 microscopy-positive cases identified in 2002, only one 2-year-old girl was symptomatic. Treatment was not given to those who were found positive only by PCR, since they were not symptomatic, and the PCR tests were done later using stored samples.
Seroepidemiology. In 1998 on Aneityum (Fig. 1c) of 675 islanders. The seropositivity rate increased with age, from 0% (0/42) for individuals born after 1996 (newborn to 1 year old) to 46.1% (54/117) for those born before 1962 (Ͼ36 years old) (P, Ͻ0.001; 2 trend, 139.1). Only 1 of 195 children born after 1991 (Ͻ7 years old) was seropositive. The seropositivity rate for individuals born between 1982 and 1991 (7 to 16 years old) was as low as that of individuals born after 1991, with 1 of 157 individuals seropositive.
IgG antibodies for any recombinant P. vivax CSP were detected in 6 individuals out of 100 islanders. Among these seropositive individuals, 4 had antibodies for both VK210 and VK247, and 1 of these 4 was born between 1982 and 1991. The seropositivity rate for CSPs among adults born before 1962 was 26.3% (5/19) (Fig. 1c) . Seroconversion rates (SCRs) for erythrocytic antigens on Malakula (Fig. 2a and b) were higher for both P. falciparum and P. vivax than on Futuna (Fig. 2c and d) . Analysis of SCRs for both parasite species on Aneityum showed that a model with 2 serocon- version rates fitted better than a model with a single SCR, with the change point in the SCR set at approximately the same time as the change in transmission due to the elimination efforts on the island (Fig. 2e and f) . Current SCRs for both P. falciparum and P. vivax are close to zero and are 10-to 20-fold lower than preelimination levels.
Parasite antigen diversity. P. vivax cases from Aneityum in 2002 showed very limited diversity in both Pvmsp1 and Pvcsp compared with cases from 6 other Vanuatu islands. First, mixedgenotype infections were rarely seen on Aneityum (0/27 P. vivax cases had mixed Pvmsp1 genotypes, and 1/26 cases had mixed Pvcsp genotypes), whereas 26% of cases (46/178) had mixed Pvmsp1 genotypes and 56% (97/174 cases) had mixed Pvcsp genotypes on the other islands. Second, the number of Pvmsp1 and Pvcsp haplotypes was also very small on Aneityum (Fig. 3) . We detected 8 single nucleotide polymorphisms (SNPs) in the sequenced region of Pvmsp1 block 5 in a total of 165 cases from Aneityum and 6 other islands of Vanuatu ( Table 1 ). All of them, except for G/A at 2017, were detected as a single haplotype (Van-M-2). In contrast, the number of tandem repeats of Q in block 6 was highly variable, and thus, in total, 14 distinct Pvmsp1 haplotypes were identified ( Table 1 ). The number of haplotypes on Aneityum was 2, whereas it ranged from 4 to 10 on other islands (Table 1 and Fig. 3 ). In Pvcsp, there were 3 SNPs, 2 insertions/ Tables 1 and 2 for the detailed haplotype classifications for Pvmsp1 and Pvcsp, respectively. Parasite rates detected during the case selection surveys on these islands are presented on the map. The inset map shows the location of Vanuatu in Oceania. )3Q2  1  1  2  1   Total  33  34  22  20  14  15  27 a Data are codons, with changed nucleotides underlined and resulting amino acid changes in parentheses. b Q, CAA; (QQQ), CAGCAACAA; (Q/E), CAG/GAG. The number of tandem repeats is listed after each motif. c See Fig. 3 . Values are numbers of incidences of each haplotype on each island.
TABLE 1 Distribution of P. vivax msp1 haplotypes on 7 islands of Vanuatu

Van-M-1 GGC (G) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q2
8 8 12 11 4 2 25
Van-M-2 GGC (G) GAT (D) TTT (F) CCA (P) CAG (Q) GCC (A) ACC (T) Q8Q2 4 2 Van-M-3 GGC (G) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q7(QQQ)2Q2 4 5 4 1 Van-M-4 GGC (G) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q6P(QQQ)3Q2 2 Van-M-5 GGC (G) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q4(QQQ)4Q2 1 Van-M-6 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A)
Q2 4 9 5 6 3
Van-M-7 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q7(QQQ)4Q2 2 1 Van-M-8 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q7(QQQ)2Q2 1 Van-M-9 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q5(QQQ)5Q2 4 1 Van-M-10 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q5((Q/E)QQ)5Q2 1 1 Van-M-11 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q5(QQQ)4Q2 3 4 Van-M-12 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q4(QQQ)5Q2 1 7 2 Van-M-13 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q4(QQQ)
4Q2 4 3 2 2 1
Van-M-14 AGC (S) GAC (D) TTC (F) CCC (P) GAG (E) AGC (S) GCC (A) Q4(QQQ
deletions, and various numbers of 9-mer oligopeptide repeats (types VK210 and VK247) and 4-mer (GGNA) repeats in a total of 125 cases from 7 Vanuatu islands (Table 2 ). In the nonapeptide repeats, the VK210 type was frequently seen, but the VK247 type was rare (Table 2) . No VK247 types were detected on Aneityum, while both types were found on 6 other islands. In total, 24 distinct Pvcsp haplotypes were identified ( Table 2 ). The number of haplotypes on Aneityum was 2, whereas it ranged from 6 to 10 on the other islands (Table 2 and Fig. 3 ). When the Pvmsp1 and Pvcsp haplotypes were combined (n, 113), the difference in the number of genotypes between Aneityum (n, 2) and comparison islands (n, 6 to 24) was more pronounced than with single-locus comparisons, with remarkably low genotype diversity (i.e., expected heterozygosity) on Aneityum (h, 0.15) and high genotype diversities on 6 comparison islands (h, 0.89 to 1.0) ( Table 3) . Only 2 genotypes, M1-C7 and M12-C6, were found on Aneityum; the former was not found on other islands, and the latter was found on Tanna. However, both the M1 (Pvmsp1) haplotype and the C7 (Pvcsp) haplotype were detected on both Tanna and Santo (Tables 1 and 2) .
Closer looks into the distributions of SNPs of Pvmsp1 and Pvcsp revealed that all SNPs were shared among islands (Tables 1  and 2 ). In contrast, repeat variations were extensive, and some repeat types were occasionally unique to individual islands, as were Pvmsp1 M4 on Santo, M5 on Gaua, and M8 on Malakula and Pvcsp C4 on Ambae, C20 on Pentecost, and C21 to C24 on Santo (Tables 1 and 2 ).
DISCUSSION
During the 2002 malaria outbreak on Aneityum, 11 years after the beginning of the 1991 elimination program, P. vivax infections were identified by microscopy (Ͼ80 parasites/l of blood) primarily in people born after 1991 (i.e., without any previous malaria exposure). In contrast, low-density parasite infections detected by PCR only (Ͻ80 parasites/l of blood) were seen in individuals born before 1991. One explanation could be that older individuals have some protective immunity, which prevents and/or limits infection (18) . Such long-term protection has been observed previously in studies with neurosyphilitics (19, 20) . While the present study did not directly examine protection from clinical infection, these results suggest that individuals born before malaria elimination had sufficient exposure to generate persistent immunity that suppresses the level of P. vivax infection but not the infection itself. Moreover, the PCR positivity rate for P. vivax reinfection was significantly lower among individuals exposed more than 10 years previously, suggesting that the immunity that suppresses the establishment of P. vivax infection could also persist in this population, a phenomenon that may be related in part to seropositivity for CSPs, which was observed only in adults.
Our data are consistent with a previous report from the central highlands of Madagascar, where a falciparum malaria epidemic started in the mid-1980s in an area in which this disease had been absent for almost 3 decades (21) . During this epidemic, individuals older than 40 years were more protected against clinical falciparum malaria than younger individuals. Nevertheless, older individuals were not protected from reinfection but had lower levels of parasitemia overall (22) . Furthermore, in highland areas of low and unstable P. falciparum transmission in Kenya, parasite density was lower in the area of higher transmission only in persons Ն15 years of age, supporting the idea that control of parasitemia may require immunity that comes with increased age and exposure (23) . The PCR-positive malaria infections detected in the visitors to Aneityum in August 2000 indicated a high potential for malaria reintroduction due to human movement. These cases originated from various islands (see Table S5 in the supplemental material) and roughly reflected the geographical patterns of malaria prevalence observed in these islands (6) . For example, the 2 PCR-positive infections detected in Aneityum islanders during August 2000 support the idea that malaria parasites brought to the island by visitors could have triggered the 2002 epidemic. The community microscopists on Aneityum first reported an unusual increase in the number of cases in early 2002. Radical treatment with primaquine usually is not administered to patients with infections detected in peripheral health facilities, and the "Chesson" strain of P. vivax (24) in this region may have a short relapse pattern. Therefore, the P. vivax infections detected in our surveys might comprise new infections, relapses, and reinfections due to a time gap of several months between the start of the epidemic and our populationwide surveys. Although we have no detailed information on these initial cases, this time gap may explain why most of the children found positive by our surveys on Aneityum in 2002 were also asymptomatic.
Before elimination, the age patterns of parasite prevalence were initially similar on Aneityum and Malakula Islands, as reflected by the seroconversion curves. The rates of P. vivax parasite infection on Aneityum in 1991, before elimination, generally decreased with age; they were 23%, 10%, 1%, and 1% in the age groups 0 to 5, 6 to 15, 16 to 30, and Ͼ30 years, respectively (7). These age patterns were seen under conditions of ongoing transmission, but our results showed that they were maintained in a population with no exposure in the past 7 to 10 years. This might reflect two possible, non-mutually exclusive components: acquired immune protection in adults and/or intrinsic susceptibility to infections in children (25) .
Antibodies typically reflect cumulative exposure and thus can potentially be used to reconstruct the history of exposure. To determine whether observed differences in parasite rates were related to antibody levels, an age-specific seroprevalence study was conducted. On Aneityum, the age-adjusted profiles of antibodies to whole-parasite extracts of both P. falciparum and P. vivax clearly showed higher levels in individuals born before the 1991 malaria elimination program, which are comparable to the antibody levels seen on Malakula, an area of mesoendemicity, indicating greater malaria exposure for individuals born before 1991. Statistical analysis of the age seroprevalence curves indicate a significant change in the SCR approximately 15 years prior to the 1998 survey, i.e., several years before the initiation of the elimination program in 1991. This discrepancy may be due to both technical and biological factors. The relatively small sample size means that the precision around the estimates of the time of change in the SCR is limited, with an SD of Ϯ4 years. Also, it is probable that antibody responses in young children at the initiation of the elimination program would not be sufficiently established, so that these children would serorevert relatively quickly. This would lead to a change point earlier than expected, as has been shown with other serological analyses of malaria control projects (26) .
SCR profiles indicate that the exposure levels for individuals born after malaria elimination on Aneityum were similar to those seen on Futuna, where malaria is not endemic. How these population-level antibody responses relate to protection from infection is not clear, although the data suggest that a greater breadth and magnitude of response to parasite antigens is advantageous (27) . The seroepidemiological results and the distribution of infections Tables 1 and 2 , respectively. b Islands are ordered from north to south (refer to Fig. 3) . Historically, transmission decreases as one goes south in the archipelago (6) .
during the 2002 Aneityum outbreak among children born after 1991 would appear to confirm the low immunity of this age group, presumably reflecting a lack of exposure. This contrasts with the pattern for older individuals, who had very few infections and higher antibody responses. The prevalence of antibodies to P. vivax CSP antigens was lower than that to erythrocyte-stage antigens, although they showed similar age profiles. This is not surprising given that whole-parasite extracts are multiantigenic, and CSP is known to be less immunogenic than blood-stage antigens, inducing antibodies with shorter half-lives (28) . An important ancillary observation is the slight but measurable malaria antibody seroprevalence in older age groups on Futuna, where Anopheles mosquitoes and malaria transmission are absent ( Fig. 2c and d) . During the surveys on Futuna, in 1992 and 1997, no parasite-positive cases were detected (7) . We believe that the mobile nature of this population can explain the seropositivity detected. Because this island is a Polynesian outlier with limited resources, many Futuna families stay off the island for periods ranging from a few months to 10 years. The village of Port Patrick on Aneityum is a Futuna community, where a parasite rate of 17% was recorded before the intervention in 1991 (7) . In contrast, interisland human movement is unlikely to explain the high seroprevalence observed in adults on Aneityum, since this island has abundant resources and population movement is infrequent. However, this limited movement could explain the low seroprevalence in the children born after elimination on Aneityum.
It was not our intention to link the serological and parasitological surveys directly, given the difference in the timing of the surveys and the fact that the former assesses population-level exposure to infection rather than directly examining immunity in more detail. The precise determinants of immunity to malaria are not known, but it is widely agreed that IgG plays a major role (29) . Protective levels of IgG are thought to be rapidly lost without rechallenge (30) . Some field observations appear to support this idea: after nonsustained elimination attempts, P. falciparum resurgence has been recorded in various African islands (21, 31, 32) and resurgence of both P. falciparum and P. vivax in several Asian countries (33) . In contrast, and in line with our results, malariaspecific antibodies have been found to persist in the absence of infection for at least 10 years after isolated outbreaks (22, 34) , in African adults several years after emigration to countries where malaria is not endemic (35) , and in Brazilian individuals after a P. vivax outbreak (36) . Our data are also consistent with reports of the persistence of antibodies to P. vivax MSP-1 19 more than 30 years after elimination (37) . One model has suggested that antibody responses to P. falciparum MSP-1 19 have a half-life as long as 40 years in areas of endemicity (38) . Our data show that the seroprevalences of antibodies against both P. falciparum and P. vivax schizont extracts in individuals born before 1982 were still moderate (i.e., approximately 50% were seropositive) and that the seroprevalence in individuals born between 1982 and 1991 was lower on Aneityum than on Malakula, suggesting that the antibody half-life also depends on the length of previous exposures to parasites.
Although the current explanations of long-term antibody production and memory include low-grade chronic infection, antigen-antibody complexes, or cross-reactivity, all of which involve continuous antigenic stimulation, an alternative model is based on protection by long-lived plasma cells without restimulation (39) . In line with the latter model, it was shown recently that individuals from an area of northern Thailand with an extremely low level of malaria transmission had antibody and B-cell memory responses to malaria antigens that were stable and were independently maintained over time in the absence of reinfection (40) . Long-lasting cellular immunity has also been detected in Caucasians last exposed to P. vivax sporozoites as long as 49 years ago, with the persistence of T-cell memory for P. vivax epitopes (41) .
High rates of infections with mixed parasite clones were observed in P. vivax cases from islands with continuous malaria transmission (6) , in sharp contrast with the near-complete absence of mixed infections in 140 P. falciparum cases previously reported for Pfmsp1 antigen alleles on these islands (42) . Furthermore, P. vivax antigen haplotypes were quite diverse on islands with continuous malaria transmission. These results indicate a heterozygous nature of P. vivax parasites even in low-transmission settings, in agreement with previous results (43, 44) .
However, infections with mixed parasite clones were almost absent among P. vivax cases during the 2002 Aneityum outbreak, a decade after the beginning of the elimination program (7) . When haplotypes of Pvmsp1 and Pvcsp were combined, infections were genetically limited, with only 1 major and 1 minor genotype. The minor genotype was also found on Tanna. Importantly, all haplotypes (two msp1 and two csp haplotypes) on Aneityum were found on Tanna, and at least one of them was also found on the other five islands. Considering a situation of rapid genotype change, because of potentially frequent meiotic recombination events inferred from high rates of mixed-haplotype infections, our results suggest that recent importation of parasites via interisland human movements within Vanuatu may be the source of the 2002 malaria outbreak on Aneityum. However, we cannot distinguish whether the minor parasite line on Aneityum was generated from two independent imports or was due to heterogeneous relapses from a single import (44) . A focal outbreak of P. falciparum malaria caused by a clonal parasite line was documented on Santiago Island, Cape Verde (32), and among Amazonian Yanomami Amerindians (45) . A previous study conducted during a malaria epidemic in the eastern highlands of Papua New Guinea showed that all P. falciparum infections shared a single genotype, suggesting external introduction as the epidemic source, while the P. vivax infections were highly diverse, suggesting endemic transmission (46) . To our knowledge, the 2002 Aneityum outbreak is the first documented outbreak of P. vivax malaria caused by a semiclonal parasite line.
Our sequence results indicate stable SNPs, but rapid evolution of repeat length polymorphisms, in the P. vivax antigen loci in Vanuatu with a limited gene pool. This is compatible with the previous observations of P. falciparum populations from Vanuatu islands (47) . Probably the human population born before the beginning of the malaria elimination program in 1991 on Aneityum had previously encountered the parasite antigen haplotypes, represented by the stable SNPs, introduced during the resurgence in 2002. It is also likely that continuous parasite exposure in this age group before malaria elimination resulted in immunity that is effective across strains (48) .
Taken together, our data suggest that P. vivax-specific antibodies persist a decade after the initiation of elimination efforts and that these antibodies may remain effective. This effectiveness may be more pronounced if the complexity and diversity of the infecting parasites are increasingly limited (19, 49) , as appears to be the case on Aneityum. These study results have implications for ma-laria elimination campaigns in areas of P. vivax prevalence and support the importance of protective measures against clinical diseases targeted at young populations born after malaria elimination. However, interventions that include populations of all ages may remain critical to sustaining malaria elimination, since submicroscopic infections may contribute to maintaining transmission (50, 51) .
